Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Reilly

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1996
Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine modelJ Luna, T Tobe, S A Mousa, et al.
Gene|December 15, 1990
High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coliW P Sisk, G L Davis, D Kingsley, et al.
Life Sciences|January 1, 1994
Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) releaseS A Mousa, J Bozarth, M Forsythe, et al.
Coronary Artery Disease|November 1, 1994
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728S A Mousa, M S Forsythe, M Diemer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Analysis of the thrombin inhibitor DuP 714 by an enzyme-linked immunosorbent assayT J Mitchell, R M Knabb, D D Christ, et al.
Thrombosis and Haemostasis|June 1, 1992
Comparison of recombinant plasminogen activator inhibitor-1 and epsilon amino caproic acid in a hemorrhagic rabbit modelA L Racanelli, M J Diemer, A C Dobies, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1989
Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibodyP C Wong, W A Price, T M Reilly, et al.
European Journal of Pharmacology|June 5, 1992
Monoclonal antibodies to the nonpeptide angiotensin II receptor antagonist, losartanT M Reilly, D D Christ, J V Duncia, et al.
Journal of Cardiovascular Pharmacology|April 1, 1994
Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosisW E Rote, J H Davis, S A Mousa, et al.
Thrombosis and Haemostasis|April 25, 1989
Monoclonal antibodies to tissue-type plasminogen activator which prolong its clearance in vivoT M Reilly, R M Knabb, A T Chiu, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1996
Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine modelJ Luna, T Tobe, S A Mousa, et al.
Gene|December 15, 1990
High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coliW P Sisk, G L Davis, D Kingsley, et al.
Life Sciences|January 1, 1994
Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) releaseS A Mousa, J Bozarth, M Forsythe, et al.
Coronary Artery Disease|November 1, 1994
Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728S A Mousa, M S Forsythe, M Diemer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1994
Analysis of the thrombin inhibitor DuP 714 by an enzyme-linked immunosorbent assayT J Mitchell, R M Knabb, D D Christ, et al.
Thrombosis and Haemostasis|June 1, 1992
Comparison of recombinant plasminogen activator inhibitor-1 and epsilon amino caproic acid in a hemorrhagic rabbit modelA L Racanelli, M J Diemer, A C Dobies, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1989
Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibodyP C Wong, W A Price, T M Reilly, et al.
European Journal of Pharmacology|June 5, 1992
Monoclonal antibodies to the nonpeptide angiotensin II receptor antagonist, losartanT M Reilly, D D Christ, J V Duncia, et al.
Journal of Cardiovascular Pharmacology|April 1, 1994
Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosisW E Rote, J H Davis, S A Mousa, et al.
Thrombosis and Haemostasis|April 25, 1989
Monoclonal antibodies to tissue-type plasminogen activator which prolong its clearance in vivoT M Reilly, R M Knabb, A T Chiu, et al.
Pageof 8